Quick Answer
BeOne Medicines Ltd. reported Gross Profit of $4.67 billion for fiscal year 2025.
BeOne Medicines Ltd. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $4.67B | +45.3% |
| 2024 | $3.22B | +54.7% |
| 2023 | $2.08B | +84.1% |
| 2022 | $1.13B | +11.7% |
| 2021 | $1.01B | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.22B | +46.3% | +5.7% |
| June 30, 2025 | $1.15B | +45.5% | +20.8% |
| March 31, 2025 | $952.28M | +51.9% | +14.6% |
| September 30, 2024 | $831.14M | +21.3% | +5.1% |
| June 30, 2024 | $791.03M | +58.4% | +26.2% |
| March 31, 2024 | $626.72M | +71.2% | -8.5% |
| September 30, 2023 | $685.00M | — | +37.2% |
| June 30, 2023 | $499.27M | — | +36.4% |
- BeOne Medicines Ltd. showed an increase of +45.3% in Gross Profit compared to the prior fiscal year.
- Over the 2021–2025 period, BeOne Medicines Ltd.’s gross profit has grown by 362.2% (from $1.01 billion to $4.67 billion).
- The most recent figure is from BeOne Medicines Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: